Phreesia/$PHR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Phreesia
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
Ticker
$PHR
Sector
Primary listing
NYSE
Employees
2,082
Headquarters
Website
Phreesia Metrics
BasicAdvanced
$1.9B
-
-$0.73
0.74
-
Price and volume
Market cap
$1.9B
Beta
0.74
52-week high
$32.76
52-week low
$17.07
Average daily volume
666K
Financial strength
Current ratio
1.946
Quick ratio
1.499
Long term debt to equity
2.326
Total debt to equity
5.623
Interest coverage (TTM)
-16.58%
Profitability
EBITDA (TTM)
-22.117
Gross margin (TTM)
68.02%
Net profit margin (TTM)
-9.83%
Operating margin (TTM)
-8.51%
Effective tax rate (TTM)
-7.39%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
-5.98%
Return on equity (TTM)
-15.97%
Valuation
Price to revenue (TTM)
4.213
Price to book
6.63
Price to tangible book (TTM)
14.91
Price to free cash flow (TTM)
83.527
Free cash flow yield (TTM)
1.20%
Free cash flow per share (TTM)
0.377
Growth
Revenue change (TTM)
16.29%
Earnings per share change (TTM)
-65.83%
3-year revenue growth (CAGR)
23.93%
3-year earnings per share growth (CAGR)
-37.96%
What the Analysts think about Phreesia
Analyst ratings (Buy, Hold, Sell) for Phreesia stock.
Bulls say / Bears say
: Adjusted EBITDA jumped to $20.8 million in Q1 FY26 from $4.1 million a year earlier, demonstrating significant operating leverage and margin expansion (Phreesia IR)
Free cash flow turned positive at $7.5 million in Q1 FY26 compared to an outflow of $6.2 million last year, highlighting improved cash generation (Phreesia IR)
Management raised its FY26 Adjusted EBITDA outlook to $85 million–$90 million from $78 million–$88 million, reflecting confidence in sustaining operational efficiency improvements (Phreesia IR)
: FY26 revenue guidance of $472 million–$482 million suggests growth of about 13%, down from 18% in FY25, indicating a possible slowdown as the company expands (Phreesia IR)
Net loss of $3.9 million in Q1 FY26, though improved, shows GAAP profitability is still out of reach and may weigh on investor sentiment (Phreesia IR)
Total revenue per AHSC increased just 6% year-over-year to $26,283 in Q1 FY26, indicating limited growth opportunities per client as competition in health-tech intensifies (Phreesia IR)
Data summarised monthly by Lightyear AI. Last updated on 1 Sept 2025.
Phreesia Financial Performance
Revenues and expenses
Phreesia Earnings Performance
Company profitability
Phreesia News
AllArticlesVideos
Phreesia and Sesame Workshop Announce 5-Year Collaboration to Improve the Health of Millions of Children Through the Power of Sesame Street
Business Wire·2 weeks ago
Phreesia Named to the 2025 Capterra Shortlist for Patient Engagement and Medical Scheduling
Business Wire·3 weeks ago
New Research Illustrates Gaps in COPD Care and the Need for Better Patient-Provider Communication
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Phreesia stock?
Phreesia (PHR) has a market cap of $1.9B as of September 03, 2025.
What is the P/E ratio for Phreesia stock?
The price to earnings (P/E) ratio for Phreesia (PHR) stock is 0 as of September 03, 2025.
Does Phreesia stock pay dividends?
No, Phreesia (PHR) stock does not pay dividends to its shareholders as of September 03, 2025.
When is the next Phreesia dividend payment date?
Phreesia (PHR) stock does not pay dividends to its shareholders.
What is the beta indicator for Phreesia?
Phreesia (PHR) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.